Ondansetron ODT 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FBTJ9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,210
Award facts
- Contract value 100% obligated
- $2,210.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,210.28 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) on January 16, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of January 20, 2026. The awardee will perform at its corporate office location in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used to prevent nausea and vomiting, particularly in military and veteran healthcare settings supported by the Defense Logistics Agency's medical supply operations.
This delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of prescription medications, generic drugs, specialty pharmaceuticals, vaccines, and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated consistent capability to fulfill federal medical procurement requirements through open competition across multiple therapeutic domains and customer bases including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DR26FBTJ9?
SPE2DR26FBTJ9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FBTJ9 worth?
The government has obligated $2,210 on SPE2DR26FBTJ9.
Is contract SPE2DR26FBTJ9 an order under another contract?
Yes. SPE2DR26FBTJ9 is a delivery order under SPE2DR25D2002, an indefinite delivery contract.
Was contract SPE2DR26FBTJ9 competed?
The extent of competition for SPE2DR26FBTJ9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award